Ren, D., Qin, G., Zhao, J., Sun, Y., Zhang, B., Li, D., . . . Wu, H. (2020). Metformin activates the STING/IRF3/IFN-β pathway by inhibiting AKT phosphorylation in pancreatic cancer. Am J Cancer Res.
Citación estilo ChicagoRen, Dianyun, Gengdu Qin, Jingyuan Zhao, Yan Sun, Bin Zhang, Dan Li, Bo Wang, Xin Jin, y Heshui Wu. "Metformin Activates the STING/IRF3/IFN-β Pathway By Inhibiting AKT Phosphorylation in Pancreatic Cancer." Am J Cancer Res 2020.
Cita MLARen, Dianyun, et al. "Metformin Activates the STING/IRF3/IFN-β Pathway By Inhibiting AKT Phosphorylation in Pancreatic Cancer." Am J Cancer Res 2020.
Precaución: Estas citas no son 100% exactas.